Article
Europe’s Bio Revolution: Biological innovations for complex problems
-
Advances in biological science could help the world overcome its most pressing challenges in health and sustainability. Europe’s Bio Revolution could translate scientific strengths into impact.
Article
How the European biotech sector can navigate turbulent times
-
The recent market downturn has affected biotechs worldwide. But the fundamentals are still strong in Europe, where companies...
Article
Infographic: The McKinsey Biotech Innovation Index
-
Europe may be catching up with the United States in biotech innovation and funding. Its overall score on the Biotech Innovation...
Article
Infographic: Capital landscape for European biotechs is maturing, but it continues to trail the United States
-
Europe’s biotech sector has made meaningful progress in attracting capital. However, raising more capital will be essential...
Article
Infographic: Building the European biotech sector with world-class science and innovation
-
Europe is a powerhouse in scientific publishing with roughly twice the output of the United States and three times that of China....
Article
SaaS and the Rule of 40: Keys to the critical value creation metric
-
Investors reward SaaS companies that hit this operating performance marker, yet a surprisingly small number have been able to...
Article
Can European biotechs achieve greater scale in a fragmented landscape?
-
World-class science and innovation need to be matched with stronger scale-up capabilities and a broader funding base if Europe...